Evidence map›Paper›PMID 37814722›Full record

ArticleTranslational pediatrics2023

Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas.

Piedad Alba-Pavón, Itziar Astigarraga, Lide Alaña, Isabel Llano-Rivas, Blanca Gener, Lorena Mosteiro, Ricardo López-Almaraz, Aizpea Echebarria-Barona, Olatz Villate

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Piedad Alba-PavónPediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Itziar AstigarragaPediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Lide AlañaPediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Isabel Llano-RivasDepartment of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Blanca GenerDepartment of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Lorena MosteiroDepartment of Pathology, Hospital Universitario Cruces, Osakidetza, Barakaldo, Spain.
Ricardo López-AlmarazPediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Aizpea Echebarria-BaronaPediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Olatz VillatePediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
BioCruces Health research Institute · ESHospital de Cruces · ESOsakidetza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoid tumor (DT) is a fibroblastic proliferation arising in soft tissue characterized by localized infiltrative growth with an inability to metastasize but with a tendency to recurrence. Nuchal-type fibromas are benign soft tissue lesions that are usually developed in the posterior neck. The development of these neoplasms can be associated with a hereditary cancer predisposition syndrome, mainly familial adenomatous polyposis (FAP) syndrome caused by

Indexed as

Desmoid tumor (DT)germlinenext generation sequencing (NGS)nuchal-type fibroma

Identifiers

PMID37814722
PMCPMC10560355
OpenAlexW4386749813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.